Turn Therapeutics Inc. (TTRX) Debt Components
- 2026-06-30: Long-term Debt, Excluding Current MaturitiesUSD (m); Long-term DebtUSD (m); Long-Term Debt, Maturity, Year OneUSD (m); Long-Term Debt, Maturity, Year TwoUSD (m).
- 2026-06-30: Long-term Debt, Excluding Current MaturitiesUSD $6.06M; Long-term DebtUSD $7.26M; Long-Term Debt, Maturity, Year OneUSD $1.30M; Long-Term Debt, Maturity, Year TwoUSD $3.11M.
- 2026-03-31: Long-term Debt, Excluding Current MaturitiesUSD (m); Long-term DebtUSD (m); Long-Term Debt, Maturity, Year OneUSD (m); Long-Term Debt, Maturity, Year TwoUSD (m).
- 2026-03-31: Long-term Debt, Excluding Current MaturitiesUSD $5.94M; Long-term DebtUSD $7.26M; Long-Term Debt, Maturity, Year OneUSD (m); Long-Term Debt, Maturity, Year TwoUSD $1.30M.
Turn Therapeutics Inc. Debt Components
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Long-term Debt, Excluding Current Maturities USD | Long-term Debt USD | Long-Term Debt, Maturity, Year One USD | Long-Term Debt, Maturity, Year Two USD | Long-Term Debt, Maturity, Year Three USD | Long-Term Debt, Maturity, Year Four USD | Line of Credit Facility, Unused Capacity, Commitment Fee Percentage pure | Line of Credit Facility, Commitment Fee Percentage pure | Debt Instrument, Face Amount USD | Debt Instrument, Interest Rate During Period pure | Debt Instrument, Unamortized Discount, Noncurrent USD |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | 6 month · 1.00% | 6 month · 1.00% | (m) | (m) | (m) |
| 2026-06-30 | $6.06M | $7.26M | $1.30M | $3.11M | $2.86M | (m) | (m) | (m) | $7.00M | (m) | $1.12M |
| 2026-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | 3 month · 1.00% | 3 month · 1.00% | (m) | (m) | (m) |
| 2026-03-31 | $5.94M | $7.26M | (m) | $1.30M | $3.11M | $2.86M | (m) | (m) | $7.00M | (m) | $1.24M |
| 2026-03-23 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 8.00% | (m) |
| 2025-12-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 12 month · 1.00% | (m) | (m) | (m) |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GALECTIN THERAPEUTICS INC (GALT) | United States | $0.399B | -11.06 |
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 | |
| Opus Genetics, Inc. (IRD) | United States | $0.406B | -3.16 |
| RELMADA THERAPEUTICS, INC. (RLMD) | United States | $0.406B | -11.92 |
| Rezolute, Inc. (RZLT) | United States | $0.382B | -6.45 |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| DiaMedica Therapeutics Inc. (DMAC) | United States | $0.423B | -10.11 |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |